PETMED EXPRESS INC (PETS)
US7163821066 - Common Stock
Overall PETS gets a fundamental rating of 3 out of 10. We evaluated PETS against 119 industry peers in the Specialty Retail industry. PETS has a great financial health rating, but its profitability evaluates not so good. PETS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year PETS has reported negative net income.
PETS had a positive operating cash flow in the past year.
Of the past 5 years PETS 4 years were profitable.
Each year in the past 5 years PETS had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.66%, PETS is in line with its industry, outperforming 43.59% of the companies in the same industry.
PETS has a Return On Equity (-1.00%) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.66% | ||
| ROE | -1% | ||
| ROIC | N/A |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of PETS (27.51%) is worse than 71.79% of its industry peers.
PETS's Gross Margin has declined in the last couple of years.
PETS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.51% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
2. Health
2.1 Basic Checks
PETS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PETS has more shares outstanding
Compared to 5 years ago, PETS has more shares outstanding
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
PETS has an Altman-Z score of 3.87. This indicates that PETS is financially healthy and has little risk of bankruptcy at the moment.
PETS's Altman-Z score of 3.87 is fine compared to the rest of the industry. PETS outperforms 79.49% of its industry peers.
PETS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.87 |
ROIC/WACCN/A
WACC10.29%
2.3 Liquidity
A Current Ratio of 1.45 indicates that PETS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.45, PETS is in line with its industry, outperforming 56.41% of the companies in the same industry.
A Quick Ratio of 1.18 indicates that PETS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.18, PETS is doing good in the industry, outperforming 79.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.45 | ||
| Quick Ratio | 1.18 |
3. Growth
3.1 Past
PETS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.31%, which is quite impressive.
The Revenue has decreased by -4.13% in the past year.
PETS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.17% yearly.
EPS 1Y (TTM)79.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-16.1%
3.2 Future
The Earnings Per Share is expected to grow by 31.76% on average over the next years. This is a very strong growth
PETS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.08% yearly.
EPS Next Y144.46%
EPS Next 2Y38.15%
EPS Next 3Y31.76%
EPS Next 5YN/A
Revenue Next Year-7.88%
Revenue Next 2Y-2.42%
Revenue Next 3Y1.08%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PETS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PETS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PETS is valued a bit cheaper than the industry average as 73.50% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.14 |
4.3 Compensation for Growth
PETS's earnings are expected to grow with 31.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.15%
EPS Next 3Y31.76%
5. Dividend
5.1 Amount
PETS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PETMED EXPRESS INC
NASDAQ:PETS (1/6/2025, 6:51:06 PM)
After market: 4.81 +0.09 (+1.91%)4.72
-0.05 (-1.05%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners61.15%
Inst Owner Change0%
Ins Owners4.77%
Ins Owner Change10.89%
Market Cap97.52M
Analysts42.86
Price Target3.83 (-18.86%)
Short Float %7.08%
Short Ratio4.15
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)-11.13%
DP-22.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)296.08%
Min EPS beat(2)296.08%
Max EPS beat(2)296.08%
EPS beat(4)2
Avg EPS beat(4)-134.59%
Min EPS beat(4)-880.39%
Max EPS beat(4)296.08%
EPS beat(8)3
Avg EPS beat(8)-121.4%
EPS beat(12)4
Avg EPS beat(12)-90.48%
EPS beat(16)4
Avg EPS beat(16)-71.39%
Revenue beat(2)0
Avg Revenue beat(2)-11.34%
Min Revenue beat(2)-11.51%
Max Revenue beat(2)-11.17%
Revenue beat(4)1
Avg Revenue beat(4)-5.97%
Min Revenue beat(4)-11.51%
Max Revenue beat(4)0.31%
Revenue beat(8)1
Avg Revenue beat(8)-6.2%
Revenue beat(12)1
Avg Revenue beat(12)-6.34%
Revenue beat(16)2
Avg Revenue beat(16)-6.07%
PT rev (1m)0%
PT rev (3m)7.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)100%
EPS NY rev (3m)278.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.38 | ||
| P/FCF | N/A | ||
| P/OCF | 28.61 | ||
| P/B | 1.01 | ||
| P/tB | 1.8 | ||
| EV/EBITDA | 8.14 |
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)0.17
OCFY3.5%
SpS12.55
BVpS4.67
TBVpS2.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.66% | ||
| ROE | -1% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.51% | ||
| FCFM | N/A |
ROA(3y)2.57%
ROA(5y)8.14%
ROE(3y)2.43%
ROE(5y)9.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.27%
GM growth 5Y-3.61%
F-Score5
Asset Turnover1.78
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 61.31% | ||
| Cap/Sales | 1.67% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 59.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.45 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 3.87 |
F-Score5
WACC10.29%
ROIC/WACCN/A
Cap/Depr(3y)91.99%
Cap/Depr(5y)95.64%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y144.46%
EPS Next 2Y38.15%
EPS Next 3Y31.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.13%
Revenue growth 3Y-3.13%
Revenue growth 5Y-0.17%
Sales Q2Q%-16.1%
Revenue Next Year-7.88%
Revenue Next 2Y-2.42%
Revenue Next 3Y1.08%
Revenue Next 5YN/A
EBIT growth 1Y87.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year174.21%
EBIT Next 3Y64.55%
EBIT Next 5YN/A
FCF growth 1Y-104.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.87%
OCF growth 3Y-52.42%
OCF growth 5Y-37.46%